Fiera Capital (Canada)
MNTA

Fiera Capital (Canada)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Fiera Capital (Canada)’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,082,303
Closed -$28.5M – 762
2018
Q3 		$28.5M Sell
1,082,303
-9,716
-0.9% -$263K 0.11% 153
2018
Q2 		$22.3M Sell
1,092,019
-2,433
-0.2% -$52.2K 0.1% 167
2018
Q1 		$19.9M Sell
1,094,452
-48,027
-4% -$801K 0.09% 176
2017
Q4 		$15.9M Sell
1,142,479
-470,877
-29% -$6.37M 0.08% 197
2017
Q3 		$29.8M Sell
1,613,356
-51,515
-3% -$861K 0.14% 143
2017
Q2 		$28.1M Sell
1,664,871
-184,345
-10% -$2.81M 0.14% 144
2017
Q1 		$24.7M Sell
1,849,216
-139,064
-7% -$2.18M 0.13% 162
2016
Q4 		$29.9M Sell
1,988,280
-367,997
-16% -$4.86M 0.17% 136
2016
Q3 		$27.5M Sell
2,356,277
-52,896
-2% -$622K 0.15% 156
2016
Q2 		$26M Buy
+2,409,173
New +$24.9M 0.15% 165

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fiera Capital (Canada)'s MNTA Position: Q4 2018 in Review

Fiera Capital (Canada) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 1,082,303 shares — an estimated $28.5M sold.

Fiera Capital (Canada) first reported a position in MNTA in Q2 2016 and held it in 10 quarters. The position peaked at $29.9M in Q4 2016. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

  • Fiera Capital (Canada) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,082,303 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $28.5M.
  • Fiera Capital (Canada) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 10 quarters.
  • Fiera Capital (Canada)'s Momenta Pharmaceuticals, Inc. position peaked at $29.9M in Q4 2016.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2018, filed 12 Feb 2019.